WELL Stock Overview
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Community Narratives
Narratives bring a range of perspectives from our community.
My Notes
Capture your thoughts, links and company narrative
WELL Health Technologies Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$6.47 |
52 Week High | CA$7.36 |
52 Week Low | CA$3.41 |
Beta | 1.24 |
1 Month Change | -8.87% |
3 Month Change | 40.96% |
1 Year Change | 77.26% |
3 Year Change | 50.12% |
5 Year Change | 273.99% |
Change since IPO | 4,074.19% |
Recent News & Updates
These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well
Dec 31A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb
Nov 29Recent updates
These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well
Dec 31A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb
Nov 29When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?
Jan 13Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?
Nov 11Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?
Aug 09WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price
May 31Shareholder Returns
WELL | CA Healthcare | CA Market | |
---|---|---|---|
7D | -3.1% | 2.1% | 2.7% |
1Y | 77.3% | 32.0% | 17.3% |
Return vs Industry: WELL exceeded the Canadian Healthcare industry which returned 32% over the past year.
Return vs Market: WELL exceeded the Canadian Market which returned 17.3% over the past year.
Price Volatility
WELL volatility | |
---|---|
WELL Average Weekly Movement | 6.6% |
Healthcare Industry Average Movement | 4.3% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 18.3% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: WELL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: WELL's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | Hamed Shahbazi | well.company |
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women’s health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners.
WELL Health Technologies Corp. Fundamentals Summary
WELL fundamental statistics | |
---|---|
Market cap | CA$1.61b |
Earnings (TTM) | CA$73.43m |
Revenue (TTM) | CA$957.69m |
21.9x
P/E Ratio1.7x
P/S RatioIs WELL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WELL income statement (TTM) | |
---|---|
Revenue | CA$957.69m |
Cost of Revenue | CA$534.80m |
Gross Profit | CA$422.89m |
Other Expenses | CA$349.47m |
Earnings | CA$73.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.29 |
Gross Margin | 44.16% |
Net Profit Margin | 7.67% |
Debt/Equity Ratio | 34.9% |
How did WELL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/21 23:07 |
End of Day Share Price | 2025/01/21 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
WELL Health Technologies Corp. is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Gabriel Leung | Beacon Securities Limited |
Douglas Taylor | Canaccord Genuity |
Scott Fletcher | CIBC Capital Markets |